AKARI THERAPEUTICS PLC-ADR (AKTX) Stock Earnings & Estimates
USA - NASDAQ:AKTX - US00972G2075 - ADR
0.4736 USD
-0.06 (-10.44%)
0.4831 USD
+0.01 (+2.01%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A -100.00% | N/A | N/A | N/A | N/A 126.87% | ||||||||||||
| EBITDA YoY % growth | -1.92M | -30.58M -1,492.71% | -27.21M 11.02% | -35.04M -28.78% | -23.45M 33.08% | -16.94M 27.76% | -17.97M -6.08% | -17.21M 4.23% | -23.09M -34.17% | -16.802M 27.23% | -16.633M 1.01% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -1.92M | -30.59M -1,493.23% | -27.25M 10.92% | -35.08M -28.73% | -23.49M 33.04% | -16.96M 27.80% | -17.98M -6.01% | -17.21M 4.28% | -23.09M -34.17% | -16.806M 27.22% | -16.647M 0.95% | N/A 11.74% | N/A -20.12% | N/A -29.28% | N/A -42.47% | N/A -25.34% | N/A -19.65% | N/A 68.88% | N/A 328.86% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | -1.80 | -3.00 -66.67% | N/A -580.00% | -0.93 95.44% | N/A 78.06% | N/A 91.28% | N/A -34,318.85% | N/A 33.33% | N/A 15.00% | N/A 90.88% | N/A 1.07% | N/A -23.91% | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Q3 / 25 | Q4 / 25 | |
|---|---|---|
| EPS Q2Q % growth | -0.08 87.22% | -0.07 92.67% |
| Revenue Q2Q % growth | ||
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | -3.759M -102.95% | -3.943M 8.20% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2022 Q2Q % growth | -0.10 9.09% | % | ||
| Q1 2021 Q2Q % growth | 0.00 100.00% | 0.00 | 0.00 | % |
| Q4 2020 Q2Q % growth | 100.00% | 0.00 | % | |
| Q3 2020 Q2Q % growth | 100.00% | 0.00 | % | |
| Q2 2020 Q2Q % growth | 100.00% | 0.00 | % | |
| Q1 2020 Q2Q % growth | -0.13 13.33% | 0.00 | -0.13 | % |
| Q4 2019 Q2Q % growth | -0.39 | -0.15 | -0.24 | -163.69% |
| Q3 2019 Q2Q % growth | -0.14 | -0.12 | -0.02 | -14.38% |
| Q2 2019 Q2Q % growth | -0.25 | -0.14 | -0.11 | -81.55% |
| Q1 2019 Q2Q % growth | -0.15 | -0.05 | -0.10 | -194.12% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 33.33% | 0% | 31.11% |
| Revenue | N/A | N/A | N/A | -100% |